Reliance Chemotex Industries Limited (BOM:503162)
India · Delayed Price · Currency is INR 112.20
-3.95 (-3.40%)
At close: Aug 21, 2026
BOM:503162 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 3,685 | 3,620 | 3,586 | 3,672 | 3,649 | 3,618 | |
Revenue Growth | 2.81% | 0.95% | -2.34% | 0.63% | 0.86% | 41.52% |
Cost of Revenue | 2,114 | 2,080 | 1,756 | 1,894 | 1,922 | 1,790 |
Gross Profit | 1,570 | 1,540 | 1,830 | 1,778 | 1,727 | 1,827 |
Selling, General & Admin | 683.11 | 677.46 | 669.95 | 580.48 | 511.42 | 472.73 |
Other Operating Expenses | 479.5 | 455.6 | 836.98 | 885.4 | 862.91 | 891.56 |
Operating Expenses | 1,310 | 1,281 | 1,654 | 1,567 | 1,472 | 1,450 |
Operating Income | 260.21 | 259.16 | 176.34 | 210.65 | 255.13 | 377.7 |
Interest Expense | -251.72 | -249.05 | -173.95 | -118.29 | -85.22 | -80.03 |
Interest & Investment Income | - | - | 23.71 | 40.9 | 32.77 | 29.85 |
Currency Exchange Gain (Loss) | - | - | - | -1.02 | -0.46 | -7.48 |
Other Non Operating Income (Expenses) | 43.36 | 38.29 | -35.73 | -76.64 | -53.51 | -41.1 |
EBT Excluding Unusual Items | 51.85 | 48.41 | -9.64 | 55.59 | 148.7 | 278.94 |
Gain (Loss) on Sale of Investments | - | - | - | - | - | 0.71 |
Gain (Loss) on Sale of Assets | - | - | 0.23 | 0.06 | -6.7 | -9.38 |
Other Unusual Items | - | - | 45.98 | 0.63 | 25.08 | 3.25 |
Pretax Income | 51.85 | 48.41 | 36.57 | 56.28 | 167.08 | 273.51 |
Income Tax Expense | -3.8 | -4.21 | -3.88 | 24.18 | 42.88 | 92.19 |
Net Income | 55.65 | 52.62 | 40.45 | 32.1 | 124.19 | 181.32 |
Net Income to Common | 55.65 | 52.62 | 40.45 | 32.1 | 124.19 | 181.32 |
Net Income Growth | 23.09% | 30.07% | 26.02% | -74.15% | -31.51% | 161.60% |
Shares Outstanding (Basic) | 8 | 8 | 8 | 8 | 8 | 8 |
Shares Outstanding (Diluted) | 8 | 8 | 8 | 8 | 8 | 8 |
Shares Change | 0.03% | 0.07% | - | - | - | - |
EPS (Basic) | 7.37 | 6.97 | 5.36 | 4.26 | 16.46 | 24.04 |
EPS (Diluted) | 7.37 | 6.97 | 5.36 | 4.26 | 16.46 | 24.04 |
EPS Growth | 23.06% | 29.98% | 26.02% | -74.15% | -31.51% | 161.60% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | 208.69 | 21.29 | -746.49 | -539.24 | 113.91 |
Free Cash Flow Per Share | - | 27.65 | 2.82 | -98.96 | -71.48 | 15.10 |
Dividend Per Share | - | 0.500 | 0.500 | 1.000 | 2.500 | 2.500 |
Dividend Growth | - | 0% | -50.00% | -60.00% | 0% | 25.00% |
Gross Margin | 42.61% | 42.55% | 51.03% | 48.42% | 47.33% | 50.51% |
Operating Margin | 7.06% | 7.16% | 4.92% | 5.74% | 6.99% | 10.44% |
Profit Margin | 1.51% | 1.45% | 1.13% | 0.87% | 3.40% | 5.01% |
Free Cash Flow Margin | - | 5.76% | 0.59% | -20.33% | -14.78% | 3.15% |
EBITDA | 413.14 | 407.08 | 304.21 | 294.45 | 335.21 | 447.27 |
EBITDA Margin | 11.21% | 11.24% | 8.48% | 8.02% | 9.19% | 12.36% |
D&A For EBITDA | 152.94 | 147.92 | 127.87 | 83.8 | 80.09 | 69.56 |
EBIT | 260.21 | 259.16 | 176.34 | 210.65 | 255.13 | 377.7 |
EBIT Margin | 7.06% | 7.16% | 4.92% | 5.74% | 6.99% | 10.44% |
Effective Tax Rate | - | - | - | 42.96% | 25.67% | 33.71% |
Revenue as Reported | 3,728 | 3,658 | 3,688 | 3,715 | 3,710 | 3,684 |